Is Alzamend Neuro Inc (ALZN) overvalued? · $2.4M cap
Alzamend Neuro Inc (ALZN) is a biotechnology company listed on US.
This page asks whether Alzamend Neuro Inc (ALZN) looks expensive on cached numbers — not a short thesis.
No cached income statement for ALZN, so there is no earnings base to call rich or cheap.
ALZN currently screens at market cap $2.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ALZN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ALZN stock page for the full model, not this heading.
Not investment advice.